Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alterity Therapeutics ( (AU:ATH) ) has shared an announcement.
Alterity Therapeutics Limited announced the issuance of 312,400,200 unlisted options set to expire on August 8, 2030, with an exercise price of US$0.0086. This move, part of an employee incentive scheme, reflects the company’s strategic efforts to align employee interests with long-term growth and stability, potentially enhancing its market position and stakeholder value.
More about Alterity Therapeutics
Alterity Therapeutics Limited operates in the biotechnology industry, focusing on developing therapies for neurodegenerative diseases. The company is known for its innovative approaches in addressing conditions such as Alzheimer’s and Parkinson’s diseases.
YTD Price Performance: 30.0%
Average Trading Volume: 14,655,894
Technical Sentiment Signal: Sell
Current Market Cap: A$128.9M
Learn more about ATH stock on TipRanks’ Stock Analysis page.